Femodene (Schering) and Minulet (Wyeth) are the same monophasic combined oral contraceptive formulation of ethinyloestradiol 30μg + gestodene 75μg, marketed in Great Britain since 1987. The manufacturer claims that Femodene controls the cycle better than the current most widely used oral contraceptive, Microgynon 30 (ethinyloestradiol 30µg + levonorgestrel 150µg), and has minimal unwanted effects. Does Femodene/Minulet offer any advantage over existing preparations?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.